Skip to main content

Advertisement

Log in

Paraneoplastic aortitis in a patient with relapsed multiple myeloma successfully treated with daratumumab, bortezomib and dexamethasone

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Shimanovsky A, Alvarez Argote J, Murali S, Dasanu CA (2016) Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance. BBA Clin 6:12–18

    Article  Google Scholar 

  2. Witzens M, Moehler T, Neben K, Fruehauf S, Hartschuh W, Ho AD, Goldschmidt H (2004) Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide. Ann Hematol 83(7):467–470

    Article  Google Scholar 

  3. Osório RM, Pina S, Salero T, Coelho MV, Sousa D, Mendonça C (2020) Association of multiple myeloma and giant cell arteritis - a case report. Eur J Case Rep Intern Med 7(1):001360

    PubMed  PubMed Central  Google Scholar 

  4. Keung YK, Yung C, Wong JW, Shah F, Cobos E (1998) Association of temporal arteritis, retinal vasculitis, and xanthomatosis with multiple myeloma: case report and literature review. Mayo Clin Proc 73(7):657–660

    Article  CAS  Google Scholar 

  5. Estrada A, Stenzel TT, Burchette JL, Allen NB (1998) Multiple myeloma-associated amyloidosis and giant cell arteritis. Arthritis Rheum 41(7):1312–1317

    Article  CAS  Google Scholar 

  6. Slart RHJA, Writing group, Reviewer group, Members of EANM Cardiovascular, Members of EANM Infection & Inflammation, Members of Committees, SNMMI Cardiovascular, Members of Council, PET Interest Group, Members of ASNC, EANM Committee Coordinator (2018) FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging 45(7):1250–1269

    Article  Google Scholar 

  7. Benfaremo D, Gabrielli A (2019) Is there a future for anti-CD38 antibody therapy in systemic autoimmune diseases? Cells 9(1):77

    Article  Google Scholar 

  8. Ostendorf L, Burns M, Durek P, Heinz GA, Heinrich F, Garantziotis P, Enghard P, Richter U, Biesen R, Schneider U, Knebel F, Burmester G, Radbruch A, Mei HE, Mashreghi MF, Hiepe F, Alexander T (2020) Targeting CD38 with daratumumab in refractory systemic lupus erythematosus. N Engl J Med 383(12):1149–1155

    Article  CAS  Google Scholar 

  9. Ratnasingam S, Walker PA, Tran H, Kaplan ZS, McFadyen JD, Tran H, Teh TC, Fleming S, Catalano JV, Chunilal SD, Johnston A, Opat SS, Shortt J (2016) Bortezomib-based antibody depletion for refractory autoimmune hematological diseases. Blood Adv 1(1):31–35

    Article  CAS  Google Scholar 

  10. Mateos MV, Sonneveld P, Hungria V, Nooka AK, Estell JA, Barreto W, Corradini P, Min CK, Medvedova E, Weisel K, Chiu C, Schecter JM, Amin H, Qin X, Ukropec J, Kobos R, Spencer A (2020) Daratumumab, bortezomib, and dexamethasone versus bortezomib and dexamethasone in patients with previously treated multiple myeloma: three-year follow-up of CASTOR. Clin Lymphoma Myeloma Leuk 20(8):509–518

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ivan Krečak.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics

The patient provided informed consent for this publication. The General Hospital of Šibenik-Knin County, Croatia, does not require ethical approval for reporting individual cases or case series.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krečak, I., Ruščić, I., Zlatović, J.J. et al. Paraneoplastic aortitis in a patient with relapsed multiple myeloma successfully treated with daratumumab, bortezomib and dexamethasone. Ann Hematol 100, 1623–1624 (2021). https://doi.org/10.1007/s00277-020-04369-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-020-04369-9

Navigation